Keith Ray

Keith Ray is a notable inventor based in Babraham, GB. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that target specific interleukin receptors. With a total of 6 patents to his name, Ray's work has the potential to impact treatments for various autoimmune and inflammatory diseases.

Latest Patents

Among his latest patents is a groundbreaking invention involving polynucleotides encoding a polypeptide that binds to the interleukin-7 receptor (IL-7R). This invention provides polypeptides capable of inhibiting IL-7 and/or L-TSLP binding to IL-7R, along with constructs and pharmaceutical compositions that incorporate these polypeptides. Another significant patent focuses on polypeptides that comprise immunoglobulin chain variable domains binding to the interleukin-6 receptor (IL-6R). This invention outlines methods for using these polypeptides to treat autoimmune and inflammatory diseases, detailing the specific complementarity determining regions and framework regions involved.

Career Highlights

Keith Ray has worked with several prominent companies in the pharmaceutical sector, including Sorriso Pharmaceuticals, Inc. and Vhsquared Limited. His experience in these organizations has allowed him to refine his expertise in the development of innovative therapeutic solutions.

Collaborations

Throughout his career, Ray has collaborated with notable professionals in the field, including Scott Crowe and Mike West. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Keith Ray's contributions to biotechnology through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in treatments for autoimmune and inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.